Upamostat - An Overview
We done post hoc subgroup analyses of vaccination standing (one or more doses as opposed to no vaccination) for the reason that vaccination status is taken into account a possible effect modifier. We utilised the test for subgroup variances and thought of PLikewise, breastfeeding is not recommended during treatment with molnupiravir and for 4 days